Evaluation of the safety and immunogenicity of pneumococcal seven-valent conjugate vaccine (Prevenar®) administered in previously unvaccinated Spanish children aged 24 to 36 months

Vaccine

Volumn 23, Issue 16, 2005, Pages 1917-1922

  De Arístegui Fernández, Javier ^a   Cos Arregui, Begoña ^b   Zurimendi Carril, Ana ^c   Alday Esteban, Ma Victoria ^d   Alzua Ruiz, Javier ^e   De La Fuente Jausoro, Emma ^f   San Pedro, Inmaculada Maturana ^f   López Michelena, Ma José ^g   Mourelo Carballo, Carlos ^h   Quintanilla Sánchez, Maria Isabel ^h   Abad Therón, Inmaculada ⁱ   Cimino, Carolyn O ^j   Fletcher, Mark A ^k   Pérez Domínguez, Ana ^l  

^a HOSPITAL DE BASURTO   (Spain)

^b CS Sodupe   (Spain)

^c Clínica Euskalduna Euskalduna   (Spain)

^d C S Berango   (Spain)

^e CS Munguía ^*  (Spain)

^f CS Santutxu ^*  (Spain)

^g C S Munguía   (Spain)

^h CS Santutxu   (Spain)

ⁱ CC Zamudio   (Spain)

^j PFIZER INC   (United States)

^k Wyeth Vaccines R and D   (France)

^l Wyeth Farma   (Spain)

more..

Author keywords

Children aged 24 36 months; Safety and immunogenicity; Seven valent pneumococcal conjugate vaccine

Indexed keywords

PNEUMOCOCCUS VACCINE;

ANOREXIA; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DIARRHEA; DROWSINESS; DRUG FEVER; DRUG SAFETY; DRUG SCREENING; DRUG TOLERABILITY; ERYTHEMA; HUMAN; IMMUNOGENICITY; INJECTION SITE REACTION; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; RESTLESSNESS; SKIN INDURATION; VACCINATION; VOMITING;

EID: 20044390540     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.10.024     Document Type: Article

References (16)

1. S.L. Kaplan, E.O. Mason Jr., E. Wald, T.Q. Tan, G.E. Schutze, and J.S. Bradley Six year multicenter surveillance of invasive pneumococcal infections in children Pediatr Infect Dis J 21 2 2002 141 147
2. S. Black, H. Shinefield, B. Fireman, E. Lewis, P. Ray, and J.R. Hansen Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children Northern California Kaiser Permanente Vaccine Study Center Group Pediatr Infect Dis J 19 3 2000 187 195
3. A. Fenoll, I. Jado, D. Vicioso, A. Perez, and J. Casal Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Spain: update (1990 to 1996) J Clin Microbiol 36 12 1998 3447 3454
4. D. Floret Pediatric deaths due to community-acquired bacterial infection Survey of French pediatric intensive care units Arch Pediatr 8 Suppl 4 2001 705s 711s
5. J. Casado Flores, J. Arístegui, C. Rodrigo de Liria, J. Martinon, and C. Fernández Pérez Neumocócica y GpeEdlM. Prevalence of pneumoccal meningitis in Spanish children An Esp Pediatr 56 2002 5 9
6. E. Miller, P. Waight, A. Efstratiou, M. Brisson, A. Johnson, and R. George Epidemiology of invasive and other pneumococcal disease in children in England and Wales. Acta Paediatr Suppl 89 435 2000 11 16
7. K. Sleeman, K. Knox, R. George, E. Miller, P. Waight, and D. Griffiths Invasive pneumococcal disease in England and Wales: vaccination implications J Infect Dis 183 2 2001 239 246
8. M. Koskela, M. Leinonen, and J. Luotonen Serum antibody response to pneumococcal otitis media Pediatr Infect Dis J 1 4 1982 245 252
9. G.R. Siber, C. Priehs, and D.V. Madore Standardization of antibody assays for measuring the response to pneumococcal infection and immunization Pediatr Infect Dis J 8 Suppl. 1 1989 84 91
10. S.A. Quataert, C.S. Kirch, L.J. Wiedl, D.C. Phipps, S. Strohmeyer, and C.O. Cimino Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S Clin Diagn Lab Immunol 2 5 1995 590 597
11. H.R. Shinefield, S. Black, P. Ray, I. Chang, N. Lewis, and B. Fireman Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers Pediatr Infect Dis J 18 9 1999 757 763
12. E. Miller, P. Waight, H. Laurichesse, N. Andrews, C. Thornton, and D. Sesardic Immunogenicity and reactogenicity of acellular diphtheria/tetanus/ pertussis vaccines given as a pre-school booster: effect of simultaneous administration of MMR Vaccine 19 28-29 2001 3904 3911
13. R. Dagan, K. Igbaria, L. Piglansky, F. Van Brusteghem, V. Melot, and A. Kaufhold Reactogenicity and immunogenicity of reduced antigen content diphtheria-tetanus-acellular pertussis vaccines as a booster in 4-7-year-old children primed with diphtheria-tetanus-whole cell pertussis vaccine before 2 years of age Vaccine 17 20-21 1999 2620 2627
14. P. Laroche, M. Barrand, S.C. Wood, K. Van Hasbrouck, J. Lang, and E. Harzer The immunogenicity and safety of a new combined diphtheria, tetanus and poliomyelitis booster vaccine (Td-eIPV) Infection 27 1 1999 49 56
15. S. Meriste, E. Tamm, P. Willems, and I. Lutsar Safety and immunogenicity of combined Dtpa-IPV vaccine for primary and booster vaccination Scand J Infect Dis 31 6 1999 587 591
16. S. Stojanov, J.G. Liese, H. Bendjenana, E. Harzer, M. Barrand, and S. Jow Immunogenicity and safety of a trivalent tetanus, low dose diphtheria, inactivated poliomyelitis booster compared with a standard tetanus, low dose diphtheria booster at six-nine years of age Munich vaccine study group Pediatr Infect Dis J 19 6 2000 516 521